Advertisement
Screener

Amphastar Pharmaceuticals, Inc. (AMPH) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

2.5 / 5 stars · 60/120 Roast Me

Amphastar Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period

Amphastar Pharmaceuticals, Inc. (AMPH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 428.79 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06

  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 32.14K shares.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 396.65K shares, a 600886.36% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 7.36K shares.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 7.42K shares.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 543.00 shares, a 90.33% decline from fiscal 2022.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 5.61K shares, a 92.03% decline from fiscal 2021.
  • Amphastar Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 70.45K shares, a 93.67% decline from fiscal 2020.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month
2026-06-3032.14K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
428.79K shares
10-Q · filed 2026-08-06
428.79K shares
derived: sum of 3 quarters · filed 2026-08-06
436.15K shares
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31396.65K shares
10-Q · filed 2026-05-07
396.65K shares
derived: sum of 2 quarters · filed 2026-05-07
404.01K shares
derived: sum of 3 quarters · filed 2026-05-07
404.01K shares
derived: sum of 4 quarters · filed 2026-05-07
2025-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
7.36K shares
derived: sum of 2 quarters · filed 2026-02-26
7.36K shares
derived: sum of 3 quarters · filed 2026-02-26
7.42K shares
10-K · filed 2026-02-26
2025-09-307.36K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
7.36K shares
derived: sum of 2 quarters · filed 2025-11-06
7.42K shares
10-Q · filed 2025-11-06
2025-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
66.00 shares
10-Q · filed 2025-08-07
2025-03-3166.00 shares
10-Q · filed 2025-05-08
2023-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
43.00 shares
derived: sum of 2 quarters · filed 2024-02-29
543.00 shares
10-K · filed 2024-02-29
2023-09-3043.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
543.00 shares
10-Q · filed 2023-11-08
2023-06-30500.00 shares
10-Q · filed 2023-08-09
2022-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
0.00 shares
derived: sum of 2 quarters · filed 2023-03-01
1.70K shares
derived: sum of 3 quarters · filed 2023-03-01
5.61K shares
10-K · filed 2023-03-01
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
1.70K shares
derived: sum of 2 quarters · filed 2022-11-08
5.61K shares
10-Q · filed 2022-11-08
19.24K shares
derived: sum of 4 quarters · filed 2022-11-08
2022-06-301.70K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
5.61K shares
10-Q · filed 2022-08-09
19.24K shares
derived: sum of 3 quarters · filed 2022-08-09
29.57K shares
derived: sum of 4 quarters · filed 2022-08-09
2022-03-313.91K shares
10-Q · filed 2022-05-10
17.54K shares
derived: sum of 2 quarters · filed 2022-05-10
27.87K shares
derived: sum of 3 quarters · filed 2022-05-10
42.51K shares
derived: sum of 4 quarters · filed 2022-05-10
2021-12-3113.63K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
23.96K shares
derived: sum of 2 quarters · filed 2022-03-11
38.60K shares
derived: sum of 3 quarters · filed 2022-03-11
70.45K shares
10-K · filed 2022-03-11
2021-09-3010.33K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
24.97K shares
derived: sum of 2 quarters · filed 2021-11-09
56.83K shares
10-Q · filed 2021-11-09
60.65K shares
derived: sum of 4 quarters · filed 2021-11-09
2021-06-3014.64K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
46.49K shares
10-Q · filed 2021-08-09
50.31K shares
derived: sum of 3 quarters · filed 2021-08-09
51.09K shares
derived: sum of 4 quarters · filed 2021-08-09
2021-03-3131.85K shares
10-Q · filed 2021-05-07
35.68K shares
derived: sum of 2 quarters · filed 2021-05-07
36.45K shares
derived: sum of 3 quarters · filed 2021-05-07
47.40K shares
derived: sum of 4 quarters · filed 2021-05-07
2020-12-313.82K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15
4.60K shares
derived: sum of 2 quarters · filed 2021-03-15
15.55K shares
derived: sum of 3 quarters · filed 2021-03-15
1.11M shares
10-K · filed 2021-03-15
2020-09-30774.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
11.72K shares
derived: sum of 2 quarters · filed 2020-11-06
1.11M shares
10-Q · filed 2020-11-06
1.11M shares
derived: sum of 4 quarters · filed 2020-11-06
2020-06-3010.95K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
1.11M shares
10-Q · filed 2020-08-07
1.11M shares
derived: sum of 3 quarters · filed 2020-08-07
1.20M shares
derived: sum of 4 quarters · filed 2020-08-07
2020-03-311.10M shares
10-Q · filed 2020-05-11
1.10M shares
derived: sum of 2 quarters · filed 2020-05-11
1.19M shares
derived: sum of 3 quarters · filed 2020-05-11
1.19M shares
derived: sum of 4 quarters · filed 2020-05-11
2019-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
90.56K shares
derived: sum of 2 quarters · filed 2020-03-16
92.38K shares
derived: sum of 3 quarters · filed 2020-03-16
92.88K shares
10-K · filed 2020-03-16
2019-09-3090.56K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
92.38K shares
derived: sum of 2 quarters · filed 2019-11-08
92.88K shares
10-Q · filed 2019-11-08
96.38K shares
derived: sum of 4 quarters · filed 2019-11-08
2019-06-301.82K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
2.33K shares
10-Q · filed 2019-08-09
5.83K shares
derived: sum of 3 quarters · filed 2019-08-09
379.08K shares
derived: sum of 4 quarters · filed 2019-08-09
2019-03-31500.00 shares
10-Q · filed 2019-05-10
4.00K shares
derived: sum of 2 quarters · filed 2019-05-10
377.25K shares
derived: sum of 3 quarters · filed 2019-05-10
388.50K shares
derived: sum of 4 quarters · filed 2019-05-10
2018-12-313.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
376.75K shares
derived: sum of 2 quarters · filed 2019-03-15
388.00K shares
derived: sum of 3 quarters · filed 2019-03-15
388.38K shares
10-K · filed 2019-03-15
2018-09-30373.25K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
384.50K shares
derived: sum of 2 quarters · filed 2018-11-09
384.88K shares
10-Q · filed 2018-11-09
708.58K shares
derived: sum of 4 quarters · filed 2018-11-09
2018-06-3011.25K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
11.63K shares
10-Q · filed 2018-08-09
335.32K shares
derived: sum of 3 quarters · filed 2018-08-09
344.03K shares
derived: sum of 4 quarters · filed 2018-08-09
2018-03-31375.00 shares
10-Q · filed 2018-05-10
324.07K shares
derived: sum of 2 quarters · filed 2018-05-10
332.78K shares
derived: sum of 3 quarters · filed 2018-05-10
436.20K shares
derived: sum of 4 quarters · filed 2018-05-10
2017-12-31323.70K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
332.40K shares
derived: sum of 2 quarters · filed 2018-03-14
435.83K shares
derived: sum of 3 quarters · filed 2018-03-14
442.08K shares
10-K · filed 2018-03-14
2017-09-308.70K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
112.13K shares
derived: sum of 2 quarters · filed 2017-11-09
118.38K shares
10-Q · filed 2017-11-09
334.33K shares
derived: sum of 4 quarters · filed 2017-11-09
2017-06-30103.42K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
109.67K shares
10-Q · filed 2017-08-09
325.63K shares
derived: sum of 3 quarters · filed 2017-08-09
338.03K shares
derived: sum of 4 quarters · filed 2017-08-09
2017-03-316.25K shares
10-Q · filed 2017-05-10
222.20K shares
derived: sum of 2 quarters · filed 2017-05-10
234.60K shares
derived: sum of 3 quarters · filed 2017-05-10
362.05K shares
derived: sum of 4 quarters · filed 2017-05-10
2016-12-31215.95K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
228.35K shares
derived: sum of 2 quarters · filed 2017-03-15
355.80K shares
derived: sum of 3 quarters · filed 2017-03-15
461.49K shares
10-K · filed 2017-03-15
2016-09-3012.40K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
139.84K shares
derived: sum of 2 quarters · filed 2016-11-09
245.54K shares
10-Q · filed 2016-11-09
253.53K shares
derived: sum of 4 quarters · filed 2016-11-09
2016-06-30127.44K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
233.14K shares
10-Q · filed 2016-08-09
241.12K shares
derived: sum of 3 quarters · filed 2016-08-09
245.75K shares
derived: sum of 4 quarters · filed 2016-08-09
2016-03-31105.69K shares
10-Q · filed 2016-05-10
113.68K shares
derived: sum of 2 quarters · filed 2016-05-10
118.31K shares
derived: sum of 3 quarters · filed 2016-05-10
155.71K shares
derived: sum of 4 quarters · filed 2016-05-10
2015-12-317.99K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
12.61K shares
derived: sum of 2 quarters · filed 2016-03-15
50.01K shares
derived: sum of 3 quarters · filed 2016-03-15
77.32K shares
10-K · filed 2016-03-15
2015-09-304.63K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
42.02K shares
derived: sum of 2 quarters · filed 2015-11-13
69.33K shares
10-Q · filed 2015-11-13
133.67K shares
derived: sum of 4 quarters · filed 2016-03-15
2015-06-3037.40K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
64.70K shares
10-Q · filed 2015-08-13
129.04K shares
derived: sum of 3 quarters · filed 2016-03-15
874.25K shares
derived: sum of 4 quarters · filed 2016-03-15
2015-03-3127.30K shares
10-Q · filed 2015-05-14
91.64K shares
derived: sum of 2 quarters · filed 2016-03-15
836.85K shares
derived: sum of 3 quarters · filed 2016-03-15
2014-12-3164.34K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
809.54K shares
derived: sum of 2 quarters · filed 2016-03-15
861.33K shares
10-K · filed 2016-03-15
2014-09-30745.20K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
796.99K shares
10-Q · filed 2014-11-13
2014-06-3051.79K shares
10-Q · filed 2014-08-13
2013-12-31698.17K shares
10-K · filed 2015-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
MANNKIND CORP (MNKD)United States$1.058B-30.41
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
Jaguar Health, Inc. (JAGX)United States$1.184B
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87